Snowball logo
logo
GERM

ETFMG Treatments Testing and Advancements ETF

GERM • NYSE ARCA
$19.1577-$0.0552  (0.29%)
About the company
Ticker
GERM
ISIN
US26924G7631
Country
Other
Sector (GICS)
Other
Under normal circumstances, the fund invests at least 80% of its net assets in U.S.-listed equity securities or ADRs of Treatments, Testing and Advancements Companies. In general, the index seeks to be comprised of companies performing advancements in research, development, and commercialization of treatments or vaccines for infectious diseases, or engaged in the advancement of research, development, manufacturing, and provision of biological tests for patients. The fund is non-diversified.

Frequently asked questions

What is the ETFMG Treatments Testing and Advancements ETF (GERM) expense ratio?

The ETFMG Treatments Testing and Advancements ETF funds expense ratio is 0.68%.

What is ETFMG Treatments Testing and Advancements ETF (GERM) current stock price?

As of the latest data, ETFMG Treatments Testing and Advancements ETF stock price is $19.16, with a previous close of $19.21. ETFMG Treatments Testing and Advancements ETF lost -$0.06 in the last trading session, representing a -0.29% loss.

Does ETFMG Treatments Testing and Advancements ETF (GERM) pay dividends?

No. ETFMG Treatments Testing and Advancements ETF does not pay a dividend.